Unbuffered premixed ranitidine formulation

Details Unbuffered premixed ranitidine formulation Unbuffered premixed ranitidine formulation

1992-07-08

1994-04-19

Rose, Shep K.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

53425, 2065241, A61K 3134, A61L 200

Patent

active

053045718

ABSTRACT:
A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H.sub.2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.

REFERENCES:
patent: 3950333 (1976-04-01), Durant et al.
patent: 4001323 (1977-01-01), Felder et al.
patent: 4021481 (1977-05-01), Almen et al.
patent: 4024271 (1977-05-01), Durant et al.
patent: 4128658 (1978-12-01), Price et al.
patent: 4250113 (1981-02-01), Nordal et al.
patent: 4255440 (1981-03-01), Price et al.
patent: 4279819 (1981-07-01), Price et al.
patent: 4396597 (1983-08-01), Rakli et al.
patent: 4521431 (1985-06-01), Crookes
patent: 4585790 (1986-04-01), Padfield et al.
patent: 4955871 (1990-09-01), Thomas
patent: 5042975 (1991-08-01), Chien et al.
patent: 5068249 (1991-11-01), Long
patent: 5169864 (1992-12-01), Johnson et al.
Das Gupta et al C.A. 110: 44828v (1989) of J. Clin. Pharm. Ther 13(5): 329-334 (1988).
Lampsona et al C.A. 105: 11922q (1986) of Am. J. Hosp. Pharm. 43(4): 921-5 (1986).
Bullock C.A. 111: 239397q (1989) of DICP Ann. Pharmacother. 23(10) 544-546 (1989).
Sarkar et al C.A. 115: 263242f (1991) of Am. J. Hosp. Pharm. 48(10): 2184-6 (1991).
Galante et al C.A. 113: 217962b (1990) of Am. J. Hosp. Pharm. 47(7): 1580-4 (1990).
Karnes et al C.A. 110: 179377t (1989) of Am. J. Hosp. Pharm. 46(2): 304-7 (1989).
Avis "Sterile Products" in Lachman et al, The Theory and Practice of Industrial Pharmacy (2nd. Ed) (1976) pp. 586 to 591, 598 to 600.
Galante et al, Stability of Ranitidine Hydrochloride at Dilute Concentration in Intravenous Infusion Fluids at Room Temperature, American Journal of Hospital Pharmacy, vol. 47, Jul. 1990, pp. 1580-1583.
Lampasona et al, Stability of Ranitidine Admixtures Frozen and Refrigerated in Minibags, Am. Journal of Hospital Pharmacy, vol. 43, Apr. 1986, pp. 921-924.

Affiliated with

Also associated with

Rating

Unbuffered premixed ranitidine formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Unbuffered premixed ranitidine formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Unbuffered premixed ranitidine formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-19994